First Week on Tirzepatide: What to Expect From Your 2.5 mg Starting Dose

FormBlends Editorial Research. against the Zepbound and Mounjaro prescribing information and the trial publications listed under Sources.

Your first week on tirzepatide is one injection of the 2.5 mg starting dose, and the label's job for that dose is to let your body adjust, not to produce your biggest weight loss. Some people feel less hungry within days; some feel mild nausea; many feel very little. The drug is still building up, and it does not reach steady state until about 4 weeks of weekly doses. Start with our tirzepatide guide if you are new to the drug.

Key takeaways

• The label starts every adult at 2.5 mg once weekly for 4 weeks. The Zepbound label calls 2.5 mg a starting dose, not a maintenance dose.
• Tirzepatide's half-life is about 5 days, so the first dose is still in your body when the second one lands, and levels climb for about 4 weeks.
• Nausea, diarrhea, vomiting and constipation were the most common adverse events in SURMOUNT-1, mostly mild to moderate and mostly during dose escalation.
• The label does not report a day on which appetite changes begin, so this page does not give one.
• Trial weight results are measured at 72 weeks. Your first month is the on-ramp, not the destination.

Tirzepatide week 1: what the label says happens

You inject 2.5 mg once, under the skin of the abdomen, thigh or upper arm, at any time of day, with or without food. That is the whole instruction for week 1. From there, the drug's 5-day half-life means about half of the first dose is still circulating when your second dose is due at day 7. Each weekly dose adds to what is left, and the label says blood levels reach steady state after about 4 weeks. So week 1 is the lowest level of drug you will have at any point in treatment.

What you feel in that first week varies. The label lists the effects of the drug, not the day they start. Some people notice they get full faster at the first meal after the injection. Others notice nothing until the dose goes up. Neither pattern predicts your long-term result. Our how long tirzepatide takes to work page covers the timing in detail.

Side effects in the first week

The Zepbound label's most common adverse reactions are nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection site reactions, fatigue, hypersensitivity reactions, burping, hair loss and reflux. The gastrointestinal ones are the early ones. In SURMOUNT-1 they were mostly mild to moderate and clustered during dose escalation, which is the period you are entering.

Source: SURMOUNT-1, Jastreboff et al., NEJM 2022 (PubMed 35658024). Rates are for the whole 72-week trial, by the dose participants were assigned to reach; all participants started at 2.5 mg.

Two things to take from that table. First, most participants at every dose did not have nausea. Second, very few stopped because of side effects. If your first week includes queasiness, it is common and usually mild; if it includes vomiting you cannot control, severe abdominal pain, or signs of dehydration, call your prescriber, because the label warns that dehydration after gastrointestinal events can lead to acute kidney injury.

A practical first-week plan

1. Pick an injection day you can keep. The label lets you change the day later as long as at least 3 days (72 hours) pass between doses, but a consistent day makes the 4-day missed-dose rule easy to track.
2. Eat smaller meals. Tirzepatide slows stomach emptying, so a normal plate can feel like too much. Protein first, fluids through the day, and stop at the first sign of fullness. Our tirzepatide diet plan goes through this.
3. Drink fluids. Water, broth and unsweetened drinks. This is a label safety point, not a wellness tip.
4. Rotate the injection site next week. Abdomen, thigh or upper arm; a different spot each time. Mild redness at the site is a listed adverse reaction; spreading redness, hives or swelling of the face or throat is not, and needs a call.
5. Do not change the dose. The label holds 2.5 mg for 4 weeks. If the first week feels like nothing, that is expected. If it feels like too much, tell your prescriber rather than skipping or splitting a dose on your own.
6. Keep other medicines in mind. If you take insulin or a sulfonylurea, the label warns of low blood sugar and says those doses may need reducing. If you take oral contraceptives, add a barrier or non-oral method for 4 weeks after starting and after each dose increase.

Tirzepatide 1 month results: what to expect

Your first month is four injections of 2.5 mg. The publications we cite report weight at 72 weeks, not at 4 weeks, so we cannot give you a typical one-month number, and you should be suspicious of pages that do. What the label tells you is structural: at the end of week 4 you have reached steady state on the starting dose, and your prescriber can consider the first increase to 5 mg. From there the schedule allows a 2.5 mg step no sooner than every 4 weeks, up to 15 mg.

Source: Zepbound and Mounjaro prescribing information (DailyMed), dosage and administration and clinical pharmacology. The week-by-week rows are arithmetic from the label's schedule, not measured outcomes.

For the long view, SURMOUNT-1 reported mean weight changes of -15.0%, -19.5% and -20.9% at 5, 10 and 15 mg after 72 weeks, versus -3.1% on placebo. Those are the numbers your first month is building toward, over many months, not something to measure against at week 4.

What this means for compounded tirzepatide

The first week works the same way with compounded tirzepatide, with one practical difference: you draw the dose from a vial with an insulin syringe rather than using a pen. The concentration on your vial label controls the math. At 10 mg/mL as an example, 2.5 mg is 0.25 mL, or 25 units on a U-100 syringe; at 5 mg/mL it is 50 units; at 20 mg/mL it is 12.5 units. Confirm the concentration with the pharmacy before your first injection. At FormBlends, injection supplies are included, prescriptions come from independent clinicians of Recess MD LLC, and the price is $149 for the first month and $239 after, at any dose; see pricing or the assessment. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro.

Frequently Asked Questions

What happens in the first week on tirzepatide?

You take one 2.5 mg injection, and the drug begins building toward the steady state the label says arrives after about 4 weeks. Some people notice less appetite or mild nausea; many notice little. The label does not give a day on which effects begin.

Is tirzepatide week 1 supposed to cause weight loss?

The label calls 2.5 mg a starting dose meant for adjustment, not a maintenance dose. Any change in the first week is a bonus, not the goal. Trial results were measured at 72 weeks on maintenance doses of 5, 10 or 15 mg.

What are typical tirzepatide 1 month results?

The publications we cite do not report a 4-week weight figure, so we do not print one. Structurally, month 1 is four doses of 2.5 mg, ending at steady state on the starting dose, when your prescriber can consider moving to 5 mg.

What if I feel nothing in the first week?

That is common and expected at the starting dose. The drug level is at its lowest in week 1 and rises for about 4 weeks. Do not increase the dose on your own; the label holds 2.5 mg for 4 weeks.

What first-week side effects mean I should call my prescriber?

Vomiting you cannot control, severe or persistent abdominal pain, signs of dehydration, an allergic reaction such as hives or facial swelling, or symptoms of low blood sugar if you also take insulin or a sulfonylurea. Mild nausea, burping and fullness are listed common reactions.

Sources

1. Zepbound prescribing information, DailyMed, revised 08/2026.
2. Mounjaro prescribing information, DailyMed, revised 08/2026.
3. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), Jastreboff et al., New England Journal of Medicine, 2022.
4. FormBlends pricing, Form Blends LLC, verified September 5, 2026.

Next steps

See the full schedule in our tirzepatide dosage chart, and learn where and how to inject in the injection site guide. Browse the tirzepatide hub for every other tirzepatide question. Talk to a licensed clinician before starting or changing any medication. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.